CDH3 and neoplasm: The alterations of EMT-associated markers, such as: loss of epithelial genes CDH1, CDH3 and gain of mesenchymal genes CDH2 and FN1, as well as the adoption of a migratory mesenchymal phenotype were maintained in all the tumor-derived cell lines (Fig. 1C and 2B).